Newsroom

News
14 January 2019

Publication: Relative bioavailability of two novel orally dispersible tablet formulations of praziquantel

In January 2019, researchers from the Pediatric Praziquantel Consortium published the results of two Phase I pharmacokinetic studies in healthy adult...

Read more
News
10 December 2018

Pediatric Praziquantel Consortium successfully completed Phase II in Ivory Coast

The important milestone of Last Patient Last Visit (LPLV) in the clinical Phase II trial was achieved on November 17, 2018

Read more
News
29 November 2018

Astellas Global Health Foundation Launches

On 20 November 2018, Astellas Pharma Inc. announced the launch of the Astellas Global Health Foundation (AGHF): a new international philanthropic...

Read more
News
31 October 2018

From the Program Lead: We have entered the pivotal Phase III stage!

With the Phase II trial showing good results on safety and efficacy for the new orally dispersible praziquantel tablets, the Consortium has entered the...

Read more
News
31 October 2018

Schistosomiasis in Kenya: an interview with Dr. Maurice R. Odiere

The forthcoming Phase III clinical trial of the Pediatric Praziquantel (PZQ) Consortium Formulation program will be conducted in Kenya, in addition to the...

Read more
News
31 October 2018

The Pediatric Praziquantel Consortium played a leading role at schistosomiasis events in Brazil and Korea

Through a series of meetings and events, the Pediatric Praziquantel Consortium presented the latest achievements of the program and aligned further on next...

Read more
News
31 October 2018

The new SCI elimination strategy

The Schistosomiasis Control Initiative (SCI) has achieved a lot since its foundation in 2002. It has helped to establish programs against parasitic worm...

Read more
News
31 October 2018

Performance Materials at Merck KGaA, Darmstadt, Germany: Key Player towards the success of the Pediatric Praziquantel Program

Read more
News
25 October 2018

Consortium Pediatric Praziquantel presenting at the 67th ASTMH Annual Meeting

Latest clinical data will be presented by the Lead of the Consortium Pediatric Praziquantel program at the 67th ASTMH (American Society of Tropical Medicine...

Read more
News
03 October 2018

Publication: Extrapolation of praziquantel pharmacokinetics to a pediatric population

In September 2018, members of the Pediatric Praziquantel Consortium published a paper on the extrapolation of praziquantel pharmacokinetics to a pediatric...

Read more
News
31 August 2018

Nature reviews publication: Global overview of schistosomiasis research and control

While considerable progress has been made to control schistosomiasis, challenges remain as there is no vaccine available and the risk for drug resistance is...

Read more
Events
24 August 2018

Consortium Pediatric Praziquantel played an important role at the 15th International Symposium on Schistosomiasis in Brazil

Latest achievements presented by the Pediatric Praziquantel Consortium partners, Farmanguinhos and Merck, at the 15th International Symposium on...

Read more

Pages